Clinical Trials

Showing trials with last updates posted in 2026.

NCT07152184 | NOT_YET_RECRUITING | PHASE2
288 participants

Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-10-01
Completion:
2032-02-01
Conditions
  • Patient With Schizophrenia Spectrum Disorder
  • NLM Classification WM 203, Psychology:Schizophrenic Psychology
  • Schizophrenia Spectrum and Other Psychotic Disorders
Interventions
  • DRUG
No Results Yet
NCT07143838 | NOT_YET_RECRUITING | NA
12 participants

Enhancing Slow Wave Sleep in Depression

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-06-30
Completion:
2026-12-31
Conditions
  • Depression - Major Depressive Disorder
Interventions
  • DEVICE
No Results Yet
NCT07080333 | RECRUITING | NA
95 participants

MICROBIOTA AND BLADDER CANCER

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-03-23
Completion:
2028-04-30
Conditions
  • Bladder (Urothelial, Transitional Cell) Cancer
Interventions
  • BIOLOGICAL
No Results Yet
NCT07061977 | RECRUITING | PHASE3
336 participants

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2025-11-05
Completion:
2030-12-31
Conditions
  • Locally Advanced Cervical Adenocarcinoma
  • Locally Advanced Cervical Adenosquamous Carcinoma
  • Locally Advanced Cervical Squamous Cell Carcinoma
  • Stage IIIA Cervical Cancer FIGO 2018
  • Stage IIIB Cervical Cancer FIGO 2018
  • Stage IIIC1 Cervical Cancer FIGO 2018
  • Stage IIIC2 Cervical Cancer FIGO 2018
  • Stage IVA Cervical Cancer FIGO 2018
Interventions
  • PROCEDURE
  • RADIATION
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT07053436 | RECRUITING | PHASE2
300 participants

Horizon Two: HR NDMM (MMRC-100)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-04-30
Completion:
2035-10-01
Conditions
  • High Risk Newly Diagnosed Multiple Myeloma
Interventions
  • DRUG
No Results Yet
NCT07033117 | RECRUITING | NA
14000 participants

RaDIANT Health Systems Intervention

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2025-10-27
Completion:
2027-03-31
Conditions
  • End Stage Renal Disease (ESRD)
  • Kidney Disease
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page